PROVIDER INITIATED TEST - The Female Cancer Panel is a blood test that includes three tumor markers commonly used to support monitoring and evaluation of certain gynecologic and breast-related cancers. These markers are most often used to track treatment response, assess disease progression, or detect recurrence in individuals with a known cancer diagnosis, rather than for routine cancer screening.
Tumor marker levels can also be affected by non-cancerous conditions, so results are interpreted alongside clinical findings, imaging studies, and other diagnostic information.
The panel includes 3 tests:
CA 15-3: Commonly used to monitor breast cancer
CA 19-9: Associated with gastrointestinal and pancreatic cancers
CA 125: Commonly used in the evaluation and monitoring of ovarian cancer
Cancer Panel, Female (CA 15-3, CA 19-9, CA 125)
PROVIDER INITIATED TEST - The Female Cancer Panel is a blood test that includes three tumor markers commonly used to support monitoring and evaluation of certain gynecologic and breast-related cancers. These markers are most often used to track treatment response, assess disease progression, or detect recurrence in individuals with a known cancer diagnosis, rather than for routine cancer screening.
Tumor marker levels can also be affected by non-cancerous conditions, so results are interpreted alongside clinical findings, imaging studies, and other diagnostic information.
The panel includes 3 tests:
CA 15-3: Commonly used to monitor breast cancer
CA 19-9: Associated with gastrointestinal and pancreatic cancers
CA 125: Commonly used in the evaluation and monitoring of ovarian cancer
